P3 Health Partners Announces Third-Quarter and Yea
Post# of 5
YTD total revenue growth of 16%
Continued strong performance across markets, re-affirming 2023 guidance
Provides preliminary 2024 Full-Year Adjusted EBITDA guidance of +$20 million to +$40 million
News Link:
https://www.businesswire.com/news/home/202311...23-Results